Corrigendum to "Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib" [Leukemia Res. 79 (2019) 38-44].

Overview

authors

Tauchi, Tetsuzo

Ritchie, Ellen K.
Deininger, Michael
Jamieson, Catriona
Mesa, Ruben
Heaney, Mark
Komatsu, Norio
Minami, Hironobu
Su, Yun
Shaik, Naveed
Zhang, Xiaoxi
DiRienzo, Christine
Zeremski, Mirjana
Chan, Geoffrey
Talpaz, Moshe

publication date

April 24, 2019

published in

Leukemia research Journal

Identity

PubMed Central ID

PMC8153734

Scopus Document Identifier

85064532789

Digital Object Identifier (DOI)

10.1016/j.leukres.2019.04.006

PubMed ID

31029462

Additional Document Info

volume

81